Kidney grafts from HCV-positive donors: Advantages and disadvantages

Transplantation Proceedings

Volumn 42, Issue 7, 2010, Pages 2436-2446

  Maluf, D G ^a   Archer, K J ^b   Mas, V R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CADAVER KIDNEY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HUMAN; KIDNEY DONOR; KIDNEY GRAFT; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SEROLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CADAVER; DATABASES AS TOPIC; HEPATITIS C; HUMANS; KIDNEY TRANSPLANTATION; LENGTH OF STAY; LIVING DONORS; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TISSUE DONORS; WAITING LISTS;

EID: 77956454888     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.04.056     Document Type: Article

References (39)

1. C.W. Shepard, L. Finelli, and M.J. Alter Global epidemiology of hepatitis C virus infection Lancet Infect Dis 5 2005 558
2. B.J. Pereira, and A.S. Levey Hepatitis C virus infection in dialysis and renal transplantation Kidney Int 51 1997 981
3. C.M. Meyers, L.B. Seeff, and C.O. Stehman-Breen Hepatitis C and renal disease: an update Am J Kidney Dis 42 2003 631
4. F. Fabrizi, F.F. Poordad, and P. Martin Hepatitis C infection and the patient with end-stage renal disease Hepatology 36 2002 3
5. L. Finelli, J.T. Miller, and J.I. Tokars National surveillance of dialysis-associated diseases in the United States, 2002 Semin Dial 18 2005 52
6. J.I. Tokars, E.R. Miller, and M.J. Alter National surveillance of dialysis associated diseases in the United States, 1995 ASAIO J 44 1998 98
7. R.B. Fissell, J.L. Bragg-Gresham, and J.D. Woods Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS Kidney Int 65 2004 2335
8. M. Jadoul, J.L. Poignet, and C. Geddes The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study Nephrol Dial Transplant 19 2004 904
9. T. Fehr, and P.M. Ambuhl Chronic hepatitis virus infections in patients on renal replacement therapy Nephrol Dial Transplant 19 2004 1049
10. T. Kasprzyk, A. Kwiatkowski, and M. Wszola Long term results of kidney transplantation from HCV-positive donors Transplant Proc 39 2007 2701
11. F. Fabrizi, S. Bunnapradist, and G. Lunghi Transplantation in kidneys from HCV-positive donors: a safe strategy? J Nephrol 16 2003 617
12. M.A. Gentil, J.L. Rocha, and G. Rodrguez Algarra Impaired kidney transplant survival in patients with antibodies to hepatitis C virus Nephrol Dial Transplant 14 1999 2455
13. P. Mathurin, C. Mouquet, and T. Poynard Impact of hepatitis B and C virus on kidney transplantation outcome Hepatology 29 1999 257
14. D.S. Batty Jr, S.J. Swanson, and A.D. Kirk Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival Am J Transplant 1 2001 179
15. F.E. Harrell Jr Regression Modeling Strategies with Applications to Linear Models, Logistic Regression, and Survival Analysis 2001 Springer New York, NY
16. P. Royston, and D.G. Altman Regression using fractional polynomials of continuous covariates: parsimonious parametric modeling Appl Stat 43 1994 429
17. C. Legendre, V. Garrigue, and C. Le Bihan Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients Transplantation 65 1998 667
18. B.J. Periera, T.L. Wright, and C.H. Schmid The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation Transplantation 60 1995 799
19. C.O. Stehman-Breen, B.M. Psaty, and S. Emerson Association of hepatitis C virus infection with mortality and graft survival in kidney-pancreas transplant recipients Transplantation 64 1997 281
20. S.L. Orloff, C.A. Stempel, and T.L. Wright Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection Clin Transplant 9 1995 119
21. D.G. Maluf, R.A. Fisher, and A.L. King Hepatitis C virus infection and kidney transplantation: predictors of patient and graft survival Transplantation 83 2007 853
22. J.R. Bucci, C.S. Matsumoto, and S.J. Swanson Donor hepatitis C seropositivity: clinical correlates and effect on early graft and patient survival in adult cadaveric kidney transplantation J Am Soc Nephrol 13 2002 2974
23. U.H. Meier-Kriesche, A.O. Ojo, and J.A. Hanson Hepatitis C antibody status and outcomes in renal transplant recipients Transplantation 72 2001 241
24. D. Roth, J.A. Fernandez, and G.W. Burke Detection of antibody to hepatitis C virus in renal transplant recipients Transplantation 51 1991 396
25. G.A. Knoll, M.R. Tankersley, and J.Y. Lee The impact of renal transplantation on survival in hepatitis Cpositive end-stage renal disease patients Am J Kidney Dis 29 1997 608
26. T. Schussler, C. Staffeld-Coit, and J. Eason Severe hepatitis C infection in a renal transplant recipient following hepatitis C genotype mismatch transplant Am J Transplant 4 2004 1375
27. J. Garcia-Valdecasas, C. Bernal, and F. Garcia Epidemiology of hepatitis C virus infection in patients with renal disease J Am Soc Nephrol 5 1994 186
28. R.J. Johnson, D.R. Gretch, and H. Yamabe Membranoproliferative glomerulonephritis associated with hepatitis C virus infection N Engl J Med 328 1993 465
29. A. Fornasieri, M. Li, and S. Armelloni Glomerulonephritis induced by human IgMk-IgG cryoglobulins in mice Lab Invest 69 1993 531
30. G. D'Amico, and A. Fornasieri Cryoglobulinemic glomerrulonephritis: a membranoproliferative glomerulonephritis induced by hepatitis C virus Am J Kidney Dis 25 1995 361
31. C. Stehman-Breen, C.E. Alpers, and W.G. Couser Hepatitis C virus associated membranous glomerulonephritis Clin Nephrol 44 1995 141
32. D. Roth, R. Cirocco, and K. Zucker De novo membranoproliferative glomerulonephritis in hepatitis C virus infected renal allograft recipients Transplantation 59 1995 1676
33. B. Fellstrom Immune injury: is it all there is to chronic graft rejection? Nephrol Dial Transplant 10 1995 149
34. K.J. Woodside, K. Ishihara, and J.E. Theisen Use of kidneys from hepatitis C seropositive donors shortens wait list time but does not alter one-yr outcome Clin Transplant 17 2003 433
35. D. Roth, K. Zucker, and R. Cirocco A prospective study of hepatitis C virus infection in renal allograft recipients Transplantation 61 1996 886
36. P. Mathurin, C. Mouquet, and T. Poynard Impact of hepatitis B and C virus on kidney transplant outcome Hepatology 29 1999 257
37. P. Kimball, S. Verbeke, and M. Shiffman HCV core protein augments cyclosporine immunosuppression Transplant Proc 37 2005 652
38. Z.Q. Yao, S. Ray, and A. Eisen-Vandervelde Hepatitis C virus: immunosuppression by complement regulatory pathway Viral Immunol 14 2001 277
39. F.L. Luan, D.E. Schaubel, and H. Zhang Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C Transplantation 85 2008 1601